Insider · CIK 0001447149

O'Dowd Sarah A

Reports to the SEC for 3 companies · NEWARK, CA

sec.gov

Transactions

Companies

Filings

CIK

0001447149

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-02	PTGXProtagonist Therapeutics, IncA Award	Director	AAward	+2,695 sh	—	—	7,825
2026-01-02	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Director	AAward	+3,762 sh	—	—	3,762
2025-01-02	PTGXProtagonist Therapeutics, IncA Award	Director	AAward	+5,130 sh	—	—	5,130
2025-01-02	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Director	AAward	+6,584 sh	—	—	6,584
2024-05-15	ICHRICHOR HOLDINGS, LTD.A Award	Director	AAward	+3,923 sh	—	—	28,325
2024-01-02	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Director	AAward	+25.7K sh	—	—	25,700
2023-05-18	ICHRICHOR HOLDINGS, LTD.A Award	Director	AAward	+4,752 sh	—	—	24,402
2023-01-16	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-05-26	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-05-24	ICHRICHOR HOLDINGS, LTD.A Award	Director	AAward	+5,635 sh	—	—	19,650
2021-05-27	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Director	AAward	+18K sh	—	—	18,000
2021-05-11	ICHRICHOR HOLDINGS, LTD.A Award	Director	AAward	+2,526 sh	—	—	14,015
2020-08-17	PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-05-12	ICHRICHOR HOLDINGS, LTD.A Award	Director	AAward	+6,893 sh	—	—	6,893
2020-05-12	ICHRICHOR HOLDINGS, LTD.A Award	Director	AAward	+4,596 sh	—	—	11,489
2019-12-19	LRCXLAM RESEARCH CORPS Sale	Chief Legal Officer & SVP	SSale	−3,831 sh	$287.80	−$1.1M	32,084
2019-09-11	LRCXLAM RESEARCH CORPM Exercise/Conversion	Chief Legal Officer & SVP	MExercise/Conversion	+22.1K sh	$42.61	+$943K	58,007
2019-09-11	LRCXLAM RESEARCH CORPS Sale	Chief Legal Officer & SVP	SSale	−22.1K sh	$233.77	−$5.18M	35,867
2019-09-11	LRCXLAM RESEARCH CORP · Employee Stock Option (Right to Buy)M Exercise/Conversion	Chief Legal Officer & SVP	MExercise/Conversion	−22.1K sh	$42.61	−$943K	0
2019-09-06	LRCXLAM RESEARCH CORPS Sale	Chief Legal Officer & SVP	SSale	−5,000 sh	$229.07	−$1.15M	39,513
2019-09-06	LRCXLAM RESEARCH CORPG Gift	Chief Legal Officer & SVP	GGift	−3,646 sh	—	—	35,867
2019-03-01	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−4,733 sh	$176.75	−$837K	44,456
2019-03-01	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−1,004 sh	$176.75	−$177K	43,452
2019-03-01	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−799 sh	$176.75	−$141K	42,653
2019-03-01	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−486 sh	$176.75	−$85.9K	42,167
2019-03-01	LRCXLAM RESEARCH CORPA Award	Chief Legal Officer & SVP	AAward	+2,230 sh	—	—	44,397
2019-03-01	LRCXLAM RESEARCH CORP · Market-based Performance Restricted Stock UnitA Award	Chief Legal Officer & SVP	AAward	+3,717 sh	—	—	3,717
2019-03-01	LRCXLAM RESEARCH CORP · Employee Stock Option (Right to Buy)A Award	Chief Legal Officer & SVP	AAward	+5,948 sh	$176.75	+$1.05M	5,948
2019-02-11	LRCXLAM RESEARCH CORPM Exercise/Conversion	Chief Legal Officer & SVP	MExercise/Conversion	+11.2K sh	—	—	49,189
2019-02-11	LRCXLAM RESEARCH CORP · Market-based Performance Restricted Stock UnitM Exercise/Conversion	Chief Legal Officer & SVP	MExercise/Conversion	+10.1K sh	—	—	0
2018-03-22	LRCXLAM RESEARCH CORPS Sale	Chief Legal Officer & SVP	SSale	−10K sh	$224.28	−$2.24M	37,832
2018-03-08	LRCXLAM RESEARCH CORPS Sale	Chief Legal Officer & SVP	SSale	−1,835 sh	$212.64	−$390K	47,832
2018-03-01	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−1,003 sh	$190.07	−$191K	47,518
2018-03-01	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−798 sh	$190.07	−$152K	46,720
2018-03-01	LRCXLAM RESEARCH CORPA Award	Chief Legal Officer & SVP	AAward	+2,947 sh	—	—	49,667
2018-03-01	LRCXLAM RESEARCH CORP · Market-based Performance Restricted Stock UnitA Award	Chief Legal Officer & SVP	AAward	+3,684 sh	—	—	3,684
2018-03-01	LRCXLAM RESEARCH CORP · Employee Stock Option (Right to Buy)A Award	Chief Legal Officer & SVP	AAward	+2,944 sh	$190.07	+$560K	2,944
2018-02-09	LRCXLAM RESEARCH CORPM Exercise/Conversion	Chief Legal Officer & SVP	MExercise/Conversion	+12.1K sh	$165.87	+$2.01M	54,701
2018-02-09	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−5,114 sh	$165.87	−$848K	49,587
2018-02-09	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−1,066 sh	$165.87	−$177K	48,521
2018-02-09	LRCXLAM RESEARCH CORP · Market-based Performance Restricted Stock UnitM Exercise/Conversion	Chief Legal Officer & SVP	MExercise/Conversion	+8,064 sh	—	—	0
2017-06-22	LRCXLAM RESEARCH CORPS Sale	Chief Legal Officer & SVP	SSale	−10K sh	$150.92	−$1.51M	42,517
2017-03-07	LRCXLAM RESEARCH CORPS Sale	Chief Legal Officer & SVP	SSale	−2,481 sh	$118.61	−$294K	52,341
2017-03-06	LRCXLAM RESEARCH CORPS Sale	Chief Legal Officer & SVP	SSale	−3,978 sh	$117.07	−$466K	54,822
2017-03-01	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−1,056 sh	$119.67	−$126K	53,965
2017-03-01	LRCXLAM RESEARCH CORPA Award	Chief Legal Officer & SVP	AAward	+4,835 sh	—	—	58,800
2017-03-01	LRCXLAM RESEARCH CORP · Market-based Performance Restricted Stock UnitA Award	Chief Legal Officer & SVP	AAward	+6,044 sh	—	—	24,235
2017-03-01	LRCXLAM RESEARCH CORP · Employee Stock Option (Right to Buy)A Award	Chief Legal Officer & SVP	AAward	+4,832 sh	—	—	55,256
2017-02-24	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−9,363 sh	$114.90	−$1.08M	55,021
2017-02-17	LRCXLAM RESEARCH CORPF Tax Payment	Chief Legal Officer & SVP	FTax Payment	−1,258 sh	$114.90	−$145K	45,549

Recent filings

Accepted (ET)
Jan 64
O'Dowd Sarah A0001104659-26-001475
SEC(opens sec.gov)
Jan 64
O'Dowd Sarah A0001104659-25-001434
SEC(opens sec.gov)
May 174
O'Dowd Sarah A0001628280-24-024072
SEC(opens sec.gov)
Jan 44
O'Dowd Sarah A0001104659-24-001496
SEC(opens sec.gov)
May 224
O'Dowd Sarah A0001628280-23-019332
SEC(opens sec.gov)
Jan 184
O'Dowd Sarah A0001104659-23-004732
SEC(opens sec.gov)
May 274
O'Dowd Sarah A0001104659-22-065866
SEC(opens sec.gov)
May 264
O'Dowd Sarah A0001209191-22-032302
SEC(opens sec.gov)
May 284
O'Dowd Sarah A0001209191-21-036664
SEC(opens sec.gov)
May 144
O'Dowd Sarah A0001209191-21-032851
SEC(opens sec.gov)
Aug 184
O'Dowd Sarah A0001209191-20-047246
SEC(opens sec.gov)
May 144
O'Dowd Sarah A0001209191-20-029217
SEC(opens sec.gov)
Dec 234
O'Dowd Sarah A0000707549-19-000208
SEC(opens sec.gov)
Sep 134
O'Dowd Sarah A0000707549-19-000145
SEC(opens sec.gov)
Sep 94
O'Dowd Sarah A0000707549-19-000141
SEC(opens sec.gov)

Companies

Address

C/O PROTAGONIST THERAPEUTICS, INC. 7707 GATEWAY BLVD., SUITE 140

NEWARK, CA, 94560-1160